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Sickle! Cell! Disease! (SCD)! is! a! monogenic,! multi5organ! hemoglobinopathy! disorder! that! is!
highly! prevalent! in! Africa,! with! nearly! 300! 000! newborn! cases! per! year.! The! underlying!
pathophysiological! mechanism! of! the! disease! involves! alteration! of! the! normal! soft! and!
biconcave!disc!shape!of!erythrocytes,!to!that!of!a!rigid!crescent.!These!abnormal!red!blood!
cells! cause! vaso5occlusion! and! intravascular! hemolysis,! resulting! in! a! variety! of! clinical!
manifestations,! including!acute!pain!crises,!anemia,!and!damage!to!various!organs.!Kidney!
disease!is!a!clinical!proxy!of!severity,!developing!only!in!a!subset!of!patients,!and!is!subject!to!
modification! by! genetic! variations.! Indeed,! reports! have! shown! significant! association!
between! proteinuria! and! specific! genetic! variants! in! MYH9+ and! APOL1,! and! between!
estimated! Glomerular! Filtration! Rate! (eGFR)! and! End! Stage! Kidney! Disease! (ESKD)! with+
HMOX1!variants+among!adult!African!Americans!affected!by!SCD.!However,!the!association!
between!these!variants!and!micro5albuminuria,!a!primary!indicator!of!renal!dysfunction,!has!




The! aim! of! this! study! was! to! investigate! the! association! of! targeted! single! nucleotide!
polymorphisms!(SNPs)! in!APOL1,!MYH9!and!HMOX1,!as!well!as!a!5’!promoter!dinucleotide!













Molecular+ analysis:! PCR,! SNaPshot! sequencing,! TaqMan! SNP! genotyping,! capillary!
electrophoresis!and!Sanger!sequencing!were!used!to!genotype!4,!3!and!2!target!SNPs!in!MYH9+



















(n=116)! based! on! crude! albuminuria! and! ACR! data,! respectively.! Micro5albuminuria! was!
significantly!increased!with!age!(p=0.004).!!
Among! SCD! patients,! the! development! of!macro5albuminuria! was! significantly! associated!
with! the! co5inheritance! of! the! 3.7! kB! alpha5globin! gene! deletion! (p=0.03),! with! alpha5
thalassemia!having!a!protective!effect!(3.6%,!n=7!of!SCD!patients!without!the!co5inherited!3.7!
kB!alpha5globin!gene!deletion!developed!macro5albuminuria,!compared!to!0.7%,!n=1!of!SCD!






patients!and!controls.! Long! (>25)!5’!promoter!dinucleotide! repeats! for!HMOX1+ rs3074372!






























































































































































































































































oxygen! (Tracz! et! al.,! 2007),! making! it! indispensable! for! cell! function! and! survival.!
Hemoglobinopathies!are!the!most!common!monogenic!disorders!affecting!humans,!with!an!
estimated!1/7!of! the!world!population!being!unaffected!carriers! (Flint!et!al.,!1998).!These!
disorders! can! be! due! to! quantitative! or! qualitative! deficiencies! in! adult! hemoglobin!
production,! which! normally! comprises! two! α5globin! and! two! β5globin! chains! (Figure! 1).!
Quantitative! deficiencies! include! the! α5! and! β5thalassemia’s,! where! there! is! deficient!




(Flint! et! al.,! 1998).! These! disorders! display! high! prevalence! in! some! human! populations,!
particularly! those! exposed! to! the! Plasmodium+ falciparum! malaria! parasite! (Taylor! et! al.,!
2012).!This!is!particularly!relevant!in!an!African!setting,!as!this!positive!selection!results!in!the!
mutant!form!reaching!high!allele!frequencies!in!this!region!(Flint!et!al.,!1998).!!
!-globins and their very stable "/! dimers that pair to form
hemoglobin. In the highly specialized mammalian enucleated
cell, the erythrocyte, these molecules are expressed at very high
concentrations (Figure 1), resulting in a tremendously efficient
transport mechanism. The genes of myoglobin (and other
globins) separated from the "- and !-globin genes during
vertebrate evolution, and these 2 genes themselves evolved into
complex genetic loci on separate chromosomes. The numbers of
Figure 1. The X-ray determined structure of the
hemoglobin molecule and a representation of its
very high concentration in the erythrocyte. (A) The
arrangement of the "-helices (shown as tubes) in each
"! unit—one on the left and one, 180° rotated, on the
right—is shown, as are the 4 heme groups with their
iron atoms where gas molecules bind. The site of the
sickle mutations on mutant !-chains as well as the !93
conserved cysteine residues is also shown. Hemoglo-
bin molecules in the red blood cell, shown in an inset on
the right, are very tightly packed (at a concentration of
approximately 34 g/dL) and have little access to sol-
vent; this allows efficient oxygen transport by each cell
but also affects the chemical behavior of the molecules,
such as promoting sickle cell hemoglobin polymeriza-
tion upon slight deoxygenation. (B) A representation of
the quaternary structural changes in the hemoglobin
tetramer, in a top-down view, in the transition from the
oxy conformation (left) to the deoxy conformation (right).
The iron atoms shift relative to the planes of the heme
groups and a central cavity between the !-chains
opens, facilitating 2,3 BPG binding. These diagrams
are based on drawings of Irving M. Geis. Illustration by
Alice Y. Chen.
Figure 2. A diagram of the proposed evolutionary
relationships of the human globin proteins as in-
ferred from sequence analyses. NGB, neuroglobin;
CYGB, cytoglobin; MB, myoglobin. Reprinted from
Pesce et al (EMBO Rep. 2002;3:1146-1151) with per-
mission. Illustration by Alice Y. Chen.
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Figure!1:!Structure!of!the!adult!hemoglobin!molecule.!The!adult!hemoglobin!molecule!consists!of!two!
α5globin!(purple)!and!two!β5globin!(green)!chains.!The!location!of!the!sickle!hemoglobin!(HbS)!mutation!







diseases,! such! as! diabetes! (Weatherall! and! Clegg,! 2001).! SCD! is! the! most! common!
















Sickle!Cell!Anemia! (SCA),! the!most!prevalent!and!severe! form!of!SCD! (Piel!et!al.,!2013),! is!
caused!by!homozygosity!for!a!substitution!mutation!(Glu→Val)!in!the!6th!codon!of!the!β5globin!
subunit! of! adult! hemoglobin! (HbA),! facilitating! the! polymerization! of! hemoglobin! during!
Articles
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Here we used simulations from the joint posterior of the 
model parameters and HbS allele frequency at the 
observation locations to generate a posterior predictive 
distribution (PPD) for the HbS frequency surface within 
each area of interest (fi gure 2). Assuming Hardy-























Figure 2: Datapoint distribution and maps of the mean and uncertainty in the predicted HbS allele frequency
(A) Distribution of the datapoints. Red circles and blue triangles indicate surveys showing presence and absence of HbS, respectively. (B) Mean of the posterior 
predictive distribution. (C) Bayesian model-based geostatistics prediction uncertainty (posterior standard deviations) of the HbS allele frequency.
! 19!
deoxygenation.!This!polymerization!subsequently!disrupts!the!structure!and!flexibility!of!the!
erythrocytes,! converting! the!normal!biconcave!disc! shape! to! that!of!a! sickle! shape,!which!
forms!the!primary!basis!of!the!molecular!pathogenesis!of!SCD!(Rees!et!al.,!2010;!Stuart!et!al.,!
2004).!Patients!are!therefore!susceptible!to!vaso5occlusion!and!subsequent!organ!damage!
(Bartolucci! and! Galacteros,! 2012).! Heterozygotes! (HbAS)! for! the! disease! are! generally!














crises,! acute! chest! syndrome,! hypertension,! pulmonary! artery! hypertension,! and!
nephropathy!(Flanagan!et!al.,!2013;!Piel!et!al.,!2013;!Rees!et!al.,!2010;!Stuart!et!al.,!2004).!
These! phenotypes! are! the! result! of! various! consequences! of! vascular! occlusion,! including!




Figure! 3:! The! pathophysiology! of! Sickle! Cell! Disease.! The! polymerization! of! hemoglobin!
during! deoxygenation! facilitates! sickling! of! the! erythrocytes,! subsequently! causing! vaso5
occlusion.!This!results! in! infarction!and!hemolysis,!with!reperfusion!releasing!free!radicals.!
The! repeated! cycles! of! ischemia! and! reperfusion! ultimately! reduce! medullary! flow,!
subsequently! causing! kidney!disease.! These! represent! the!major!pathways! through!which!
complications!of!SCD!arise.!Adapted!from!Rees!2010!(Rees!et!al.,!2010).!
!
Sickle!erythrocytes!undergo!extensive!hemolysis! in+vivo!due! to! the!unstable!nature!of! the!
sickle!hemoglobin!molecule,!as!demonstrated!by!increased!bilirubin,!plasma!hemoglobin!and!
reticulocyte!counts,!and!reduced!plasma!haptoglobin!in!murine!models!(Belcher!et!al.,!2006;!
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diagnostic facilities means that precise data are not 
available, a recent estimate52 suggests that more than 
230 000 aff ected children are born in this region every 
year (0·74% of the births in sub-Saharan Africa), which 
is about 80% of the global total. By comparison, the 
yearly estimate of aff ected births in North America is 
2600 and 1300 in Europe52 (fi gure 3).
Little is known about sickle-cell disease in Africa.58,59 
Generally, diagnostic facilities are poor, routine 
screening is absent, and, d spite th  fact tha  most 
patients would survive if provided with a simple package 
of inexpensive interventi ns,60 ost die undi gnos d in 
early childhood.
Despite the high mortality associated with this disease 
in Africa, the causes of death in aff ected children are 
poorly documented. Although widely ascribed to two 
diseases—bacteraemia and malaria14,58—few substantial 
data are available to lend support to either potential 
cause. However, in a study undertaken in an African 
population,61 both the range of organisms and the 
frequency of bacteraemia caused by Streptococcus 
pneumoniae and Haemophilus infl uenzae in children with 
sickle-cel  d ease were similar to those reported i  
Jamaica and the USA.8,62 This fi nding suggests that, with 
prophylaxis against both H infl uenzae and S pneumoniae, 
the occurrence of bacteraemia in children with sickle-cell 
Figure 2: Pathophysiology of sickle-cell disease
The roles of HbS polymerisation, hyperviscosity, vaso-occlusion, haemolysis, and endothelial dysfunction are shown. Deoxygenation causes HbS to polymerise, leading to sickled erythrocytes. 
Vaso-occlusion results from the interaction of sickled erythrocytes with leucocytes and the vascular endothelium. Vaso-occlusion then leads to infarction, haemolysis, and infl ammation; infl ammation 
enhances the expression of adhesion molecules, further increasing the tendency of sickled erythrocytes to adhere o the vascular endothelium and to worsen vaso-occlusion. Reperfusion of the 
ischaemic tissue generates free radicals and oxidative damage. The damaged erythrocytes release free haemoglobin in to the plasma, which strongly bind to nitric oxide, causing functional nitric oxide 
defi ciency and contributing to the development of vasculopathy. HbS=sickle haemoglobin. NO=nitric oxide. VCAM=vascular cell-adhesion molecule.
Oxygenated erythrocyte containing HbS
Deoxygenated erythrocyte with polymerisation of HbS 
Dehydrated, sickled erythrocyte
Occlusion of postcapillary venules (vaso-occlusion)
Reperfusion
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inactivating NO and

















be!due!to!nitric!oxide!depletion!as!a! result!of! increased!hemolysis!commonly!seen! in!SCD!
patients,! resulting! in! increased! arterial! stiffness! (Novelli! et! al.,! 2014).! Episodic! cycles! of!










for! the! induction! of! fetal! hemoglobin! (HbF)! (Platt! et! al.,! 1984;! Ware! et! al.,! 2011).! The!
supportive! approach! is! the! most! common,! as! it! promotes! a! healthy! diet,! folic! acid!
supplementation!and!hydration! for!optimal!management!of! the!patient.!The!symptomatic!
approach,! including!blood! transfusions,! analgesia,! and! antibiotics! (Alhashimi! et! al.,! 2010),!
aims! to! alleviate! certain! symptoms! subsequent! to! their! development.! The! only! curative!
approach! available! for! SCD! is! the! transplantation! of! hematopoietic! stem! cells! (HSCs)!
(Bernaudin!et! al.,! 2007).!Nitric!Oxide! (NO)! is! the!only! current! treatment! accepted! for! the!
abortive! approach,! as! it! has! been! reported! to! permanently! terminate! the! occurrence! of!
chronic!pain!episodes!in!some!SCD!patients!(Atz!and!Wessel,!1997).!The!treatment!regime!for!
SCD!patients! is!therefore!dependent!on!the!clinical!manifestation!of!the!disease!(Pule!and!
Wonkam,! 2014).! Early! identification! of! these! clinical! events,! particularly! cardiovascular!




the! US! due! to! research! and! therapeutic! advancements! (Diallo! and! Tchernia,! 2002)! has!
decreased!morbidity!and!mortality.!Long!term!studies!in!Jamaica!and!the!US!have!shown!that!
early!detection!and!treatment!of!acute!events!(Vichinsky!et!al.,!1990),!as!well!as!hydroxyurea!
treatment! (Charache!et! al.,! 1995)! and!blood5transfusion! therapy! (Adams!et! al.,! 1998)! can!
reduce!the!severity!of!SCD!and!subsequently!improve!the!quality!of!life!of!patients!(Makani!
! 22!
et! al.,! 2007).! The!early!detection!of!possible! complications! that! could! involve! genetic! risk!
factors!can!inform!anticipatory!guidance!for!treatment!of!SCD,!is!a!fundamental!obstacle!in!
low! income!and!developing!countries,!particularly! in!Africa,!as!most!patients!have! limited!








range! from!early! childhood!mortality! to!an!almost!undetectable! condition!where!patients!
survive! to! late! adulthood! (Bartolucci! and! Galacteros,! 2012;! Sebastiani! et! al.,! 2005).! The!

















SCD,! and! has! been! shown! to! decrease! stroke! risk! in! both! Nigerian! and! African5American!
cohorts! (Enosolease! et! al.,! 2005;! Fatunde! and! Scott5Emuakpor,! 1992;! Platt! et! al.,! 1991;!
! 23!
Yetunde!and!Anyaegbu,!2001).!HbF! levels!vary!between!1530%! in!SCD!patients,!and! three!
genetic! loci! have! been! associated! with! the! variability! and! heritability! of! HbF! expression;!
BCL11A,! HBS1LSMYB! and! the! HBB! cluster! (Lettre! et! al.,! 2008;! Thein! and! Menzel,! 2009;!
Wonkam!et!al.,!2014a;!Xu!et!al.,!2010).!Recent!single!nucleotide!polymorphisms!in!a!BCL11A!
erythroid5specific!enhancer!have!been!shown!to!explain!significant!variations!in!HbF!levels!in!
a! Cameroonian! SCD!population! (Pule! et! al.,! 2015).! These! variants!may! therefore! serve! as!









Cardiovascular! phenotypes! in! SCD! include! complications! involving! the! heart! (e.g.! heart!
failure),!brain!(e.g.!stroke),!lungs!(e.g.!pulmonary!hypertension)!and!kidneys!(e.g.!proteinuria).!
Cardiovascular!disease!represents!possibly!the!most!catastrophic!complication!for!children!









these! high5income! countries.! In! the! context! of! SCD,! occlusive! vasculopathy! has! been!
identified!as!the!most!common!cause!of!cardiovascular!disease!(Stockman!et!al.,!1972).!!
!
An! increased! tricuspid! regurgitation! jet! velocity! (TRV!>! 2.5!m/s),! pulmonary! hypertension!
defined! by! right! heart! catheterization,! and! renal! failure! independently! confer! increased!
! 24!
mortality! in! SCD! (Gladwin!et! al.,! 2004;!Platt! et! al.,! 1994).!We!have! recently! reviewed! the!
epidemiology,!risk!factors!and!genetic!polymorphisms!associated!with!the!development!of!








Kidney! disease! occurs! in! 5518%! of! patients,! conferring! increased! risk! of! morbidity! and!
mortality! (Ashley5Koch! et! al.,! 2011;! Platt! et! al.,! 1994),! and! is! considered! a! characteristic!
clinical!manifestation!of!SCD.!Renal!damage!is!common!in!SCD!as!a!result!of! long5standing!
disruption! of! blood! flow! through! the! renal! medullary! capillaries! caused! by! sickled!
erythrocytes! (Sasongko! et! al.,! 2013)! due! to! the! hypoxic,! hyperosmotic! and! acidotic!
environment!(Pham!et!al.,!2000).!SCD!nephropathy!includes!proteinuria,!ischemia,!impaired!
renal! acidification,! papillary! necrosis,! hyposthenuria! and! supranormal! proximal! tubular!
function! (Pham! et! al.,! 2000;! Stuart! et! al.,! 2004).! Glomerular! enlargement! is! possibly! the!
earliest! renal! abnormality! in! SCD! (Ware! et! al.,! 2010),! with! pediatric! patients! displaying!
increased!glomerular!filtration!(Ware!et!al.,!2010;!Wigfall!et!al.,!2000)!and!proteinuria!that!




a! primary! indicator! of! glomerulopathy,! preceding! development! of! progressive! renal!
insufficiency!and!ultimate!end!stage!renal!disease!in!children!and!adult!patients!(Becton!et!
al.,! 2010;!Guasch! et! al.,! 1999,! 2006).! Combined!micro5! and!macro5albuminuria! display! an!
overall! prevalence!of!68%! in!adult! SCD!patients! (Guasch!et! al.,! 2006).! Proteinuria! is! likely!
mediated!by!chronic!hemolytic!anemia,!and!is!associated!with!stroke!(Ohene5Frempong!et!
al.,!1998)!,!acute!chest!syndrome!(Castro!et!al.,!1994),!hospitalization!(Wigfall!et!al.,!2000)!
and! increased!mortality! (Platt!et!al.,!1994)! in!pediatric!patients!with!SCD.!The!presence!of!
! 25!
albuminuria! is! also! associated!with! decreased! glomerular! filtration! rates! in! SCD! patients,!
indicating!glomerular!injury!(Ashley5Koch!et!al.,!2011;!Guasch!et!al.,!1996).!!
!








SCD! is! not! known! (Sasongko! et! al.,! 2013).! Results! of! studies! in! 8! patients!with! sickle! cell!
anemia! indicated! that! enalapril,! an! ACE! inhibitor,! may! be! useful! in! reducing! micro5
albuminuria! in! patients! (Aoki! and! Saad,! 1995).! However,! this! does! not! apply! to! levels!
following!discontinuation!of!the!treatment,!and!further!studies!are!required!to!determine!the!
effectiveness!of! this! treatment!procedure! in! a! larger! cohort! of! patients.! To! this! point,! no!






et! al.,! 2016).! Hydroxyurea! treatment!may! also! serve! to! prevent! progression! of! sickle! cell!
nephropathy!to!ESKD!(Laurin!et!al.,!2014).!Hemoglobin5mediated!oxidative!toxicity!is!also!a!















Genetic! factors! involved! in! the!development!of! kidney!disease! in! SCA!patients!are! largely!
unexplored,!however!"5thalassemia!and!HbF!play!protective!roles,!as!is!also!seen!with!stroke!

















(Arrondel! et! al.,! 2002;! Tzur! et! al.,! 2010).! The! protein! is! expressed! widely! in! the! kidney,!
particularly!in!podocyte!cells!found!in!the!renal!glomerulus!(Arrondel!et!al.,!2002;!Tzur!et!al.,!







earlier! kidney! disease5related! phenotypes! in! populations! with! varying! levels! of! African!
ancestry!inheritance!(Behar!et!al.,!2010;!Barry!I!Freedman!et!al.,!2009;!Barry!I.!Freedman!et!













Table!1:!Genetic!variants! in!MYH9!associated!with! the!development!of!proteinuria! in!SCD!
patients!
Gene! SNPs! HGVS!Nomenclature! Effect! References!
MYH9+ rs5750248! NC_000022.11:g.36306846T>C! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs8141189! NC_000022.11:g.36318665T>A! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs11912763! NC_000022.11:g.36288676G>A! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs16996648! NC_000022.11:g.36296706T>C! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs5756152! NC_000022.11:g.36316427A>G! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs16996672! NC_000022.11:g.36329925C>T! Risk! (Ashley5Koch!et!al.,!2011)!
+ rs1557529! NC_000022.11:g.36309484A>G! Risk! (Ashley5Koch!et!al.,!2011)!









Trypanosoma+ brucei+ rhodesiense+ and! T.+ brucei+ gambiense,! the! pathogens! responsible! for!




G1! consists! of! two! non5synonymous! variants! rs73885319! (p.! Ser358Gly)! and! rs60910145!
(p.Ile400Met),!while!G2!is!a!6bp!deletion,!rs71785313!(p.Asn404_Tyr405del)!(Table!2).!Due!




















variants! and! kidney! disease! in! SCD! patients,! possibly! through! enhanced! risk! of!
hemoglobinuria! (Saraf!et!al.,!2014).!Furthermore,! these!APOL1! variants!may!be! important!






Gene! SNPs! HGVS!Nomenclature! Effect! References!
APOL1+ rs73885319! NP_663318.1:p.Ser358Gly! Risk! (Ashley5Koch! et! al.,! 2011;!
Saraf!et!al.,!2015)!
+ rs60910145! NP_663318.1:p.Ile400Met! Risk! (Saraf!et!al.,!2015)!
















bilirubin,! a! potent! antioxidant! (Tenhunen!et! al.,! 1968).! The!HO51!pathway! exerts! its! anti5
inflammatory! and! vascular! protective! effects! through! the! actions! of! its! products,! carbon!
monoxide!and!bilirubin!(Figure!4),!in!the!context!of!repetitive!ischemia5reperfusion!injuries!
that! occur! with! SCD! (Jison! et! al.,! 2004).! Carbon! monoxide,! a! known! cytoprotectant! and!
vasodilator,! has! the! ability! to! suppress! proinflammatory! cytokines! and!mitigate! vascular5
cellular!interactions!during!hypoxia!(Morita!and!Kourembanas,!1995;!Otterbein!et!al.,!1999).!





the! kidney! (Tenhunen! et! al.,! 1968).! Animal! model! studies! in! transgenic! SCD! mice! have!
identified!HMOX1!as!an!ameliorator!of!both!inflammation!and!vaso5occlusion,!with!induction!
occurring!in!the!proximal!tubules!of!the!kidney!in!response!to!increased!cell!free!hemoglobin!
(Belcher! et! al.,! 2006;! Chintagari! et! al.,! 2015;! Ghosh! et! al.,! 2011).! Moreover,! the!
overexpression! of! HO51! reduced! stasis! induced! by! repeated! cycles! of! hypoxia! and! re5
oxygenation! in! transgenic! SCD! mice! (Belcher! et! al.,! 2006)! In! the! human! sickle! kidney,!
increased! expression! of! HO51! in! circulating! endothelial! cells! is! observed,! with! induction!
occurring!in!the!renal!tubules,!vasculature!and!interstitial!cells!(Nath!et!al.,!2001).!
!
pathway and downstream effectors may play a significant role in
the anti-inflammatory and vascular protective responses to ischemia-
reperfusion injury in sickle cell disease.
Chronic hemolysis in sickle cell disease requires the up-
regulation of enzyme systems to catabolize over 30 g of potentially
toxic and pro-oxidant hemoglobin released per day from hemo-
lyzed erythrocytes.27 Heme oxygenase-1, the inducible isoform of
heme oxygenase, is the rate-limiting enzyme in heme catabo-
lism.24,54-56 HO-1 is found predominantly in Kuppfer cells of the
liver and circulating and tissue monocytes; however, it has been
demonstrated in other cell types throughout the body in response to
heme exposure, inflammation, oxidant injury, and other stressors.
Heme is broken down to biliverdin by HO-1, releasing carbon
monoxide and iron. Biliverdin is converted to bilirubin by the
enzyme biliverdin reductase. Biliverdin reductase has recently
been proposed as a major catalytic antioxidant system.57 The
functional role of HO-1 extends beyond heme catabolism; its
induction is a compensatory response to tissue stress or injury and
protects from the deleterious effects of inflammation. Beneficial
effects of HO-1 include inhibition of inflammation in models of
ischemia-reperfusion and xenograft rejection, protection from
oxidant-induced injury, enhanced induction and mediation of the
anti-inflammatory effects of IL-10, inhibition of vascular smooth
Figure 4. The potential role of the heme oxygenase-1 pathway and downstream
effectors in the compensatory response to repeated ischemia-reperfusion
injury and hemolytic stress in sickle cell disease. Red text represents up-
regulated genes or molecules measured in this study in sickle cell patients. CO
indicates carbon monoxide; cGMP, cyclic guanosine monophosphate; p38MAPK,
p38 mitogen-activated protein kinase; p21, a cyclin-dependent kinase inhibitor.
Figure 5. Validation of gene expression data for the HO-1 pathway and p21. Gene expression levels are reflected as arbitrary units of fold-change of expression relative to
mean control levels. Black lines in B, C, and D are regression lines. (A) Sickle cell disease patients (red bars) have increased mean gene expression (left y-axis) of all enzymes
in the heme catabolism pathway and have higher mean serum total bilirubin (right y-axis), the end product of heme breakdown, compared with healthy volunteers (gray bars).
Error bars reflect SEM. (B) Carbon monoxide production (determined by carboxy hemoglobin levels measured by co-oximetry) was measured in 24 patients with sickle cell
disease (13 HbSS not on hydroxyurea therapy [Œ], 8 HbSS on hydroxyurea [■], 2 HbSC and 1 HbS!-thalassemia phenotype [E]). Carbon monoxide production correlates with
plasma heme levels measured by benzidine assay. (C) Carbon monoxide production correlates with HO-1 gene expression measured by microarray in these same 24 sickle
cell disease patients. (D) Serum total bilirubin levels were measured in 27 sickle cell disease patients (14 HbSS not on hydroxyurea therapy [Œ], 10 HbSS on hydroxyurea [■], 2
HbSC and 1 HbS!-thalassemia phenotype [E], and 13 controls [F]). Serum total bilirubin correlates with biliverdin reductase gene expression measured by microarray. Gene
expression levels for biliverdin reductase also correlate with CO production (r " 0.55, P # .005, data not shown). (E) HO-1 and p21 gene expression measured by microarray
and real-time PCR show increased expression in 27 sickle cell disease patients. Error bars reflect SEM. (F) Patients with sickle cell disease (n " 4) have increased cellular
HO-1 protein levels in their peripheral blood mononuclear cells compared with healthy volunteers (n " 4) as measured by Western blot. Lane 1 represents an HO-1–positive
control.
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Figure!4:!Role!of!heme!oxygenaseP1!and! the!actions!of! its!products! in!response!to!repeated!
cycles!of!ischemiaP eperfusion!injury!and!hemolytic!stress!in!SCD.!Heme!Oxygenase!catalyzes!the!










kidney! disease! through! insufficient! protection! of! the! kidney! from! hemoglobin5mediated!
toxicity! (Bean! et! al.,! 2012).!HMOX1+ rs743811! has! been! associated!with! CKD! and! ESRD! in!






Gene! SNPs! HGVS!Nomenclature! Effect! References!









Global! disparities! in! research! stem!not! only! from! lack! of! resources! but! also! from!uneven!
distribution!of!research!funding!or!poor!targeting!of!scientific! investments.! In!this!context,!




stroke,! pulmonary! hypertension! and! kidney! disease! associated! with! SCD,! and! indexed! in!
PubMed! and! Google! Scholar.! Multiple! publications! have! identified! genetic! factors! which!
contribute! to! the! development! risk! of! cardiovascular! phenotypes,! however! little! of! this!
research!has!been!conducted!in!an!African!setting.!There!is!an!urgent!need!for!genomic!(and!
multi5omics)!research!on!cardiovascular!diseases!associated!with!SCD,!particularly!in!Africa!to!
allow!for!proportional,! just,!and!ethical! investment!of!global! research! funding!on!diseases!
that!greatly!impact!the!African!continent!and!yet!remain!relatively!underfunded.!Ultimately,!
this! will! result! in! socially! responsible! research! investments! and! identification! of! at5risk!
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identification! of! genetic! polymorphisms! associated! with! these! critical! cardiovascular!
phenotypes! of! SCD! could! be! used! to! create! a! panel! of! biomarkers! to! identify! at5! risk!
individuals!and!better!inform!surveillance!and!treatment!approaches.!Limited!genetic!studies!
associated!with! critical! cardiovascular! phenotypes! in! SCD! have! been! reported! in! patients!
residing!in!Africa,!indicating!an!urgent!need!to!perform!these!studies!that!could!inform,!in!a!
unique! way,! the! global! SCD! communities! about! the! values! that! genes! and! environment!







The! aim!of! this! study!was! to!determine! the! association!between! selected! SNPs! in!MYH9,!
APOL1! and!HMOX1,! as! well! as! a! 5’! promoter! dinucleotide! repeat! in!HMOX1+with!micro5
! 33!
albuminuria!among!a!sample!of!Cameroonian!SCD!patients,!and!compare!these!results!to!that!




Glomerular! filtration! rate! (eGFR)! profile! of! SCD! patients,! as! well! as! other! clinical! and!
hematological!variables;!
























1)! A! total! of! 413! SCD! patients! were! selected,! based! on! available! cardiovascular! data,!
particularly! micro5albuminuria! and! serum! creatinine! measurements,! from! a! larger! study!
conducted!on!Sickle!Cell!Disease!patients!recruited!from!hospitals! in!Yaoundé!and!Douala,!
the!two!largest!cities!in!Cameroon.!!
2)! A! cohort! of! non5SCD!patients! (n=101)! randomly! selected! from! the! same!population! of!
apparently!healthy!patients!at!Central!Hospital,!Yaoundé.!




crisis! (VOC),! and! administration!of! hydroxyurea.!Anthropometric! variables! such! as! height,!
weight,!body!mass!index!(BMI),!and!systolic!and!diastolic!blood!pressures!(SBP!and!DBP)!were!
also!measured!for!patients.!!















Laboratory! tests! were! performed! to! measure! serum! creatinine! concentration,! urine!
creatinine!concentration,!and!the!level!of!albumin!in!the!urine!was!measured!with!either!a!






(305300! mg/mL)! and! macro5albuminuria! (>300! mg/mL).! The! ACR! data,! represented! by!
milligrams! albumin! per! millimole! creatinine,! was! defined! as! normo5albuminuria! (<3!
mg/mmol),!micro5albuminuria! (3530mg/mmol)!or!macro5albuminuria! (>30!mg/mmol).! This!














(2)!Cockcroft5Gault! (CG)! =! 140 − 56( ×@(+6ℎ*× 17
BC=DEFGFG= ×H8
×I(J2 +




















)XYℎ = (− 0.329<=>1 × 0.411<=>8 )!
max _IT = IT'U+_`IT'U ≥ 1, c*ℎ('d+I( = 1!
min _IT = IT'U`+_`IT'U ≤ 1, c*ℎ('d+I( = 1`!

























sequencing,! therefore! it! is!necessary! to!verify! the! integrity!of! the!DNA.!This!was!achieved!
using! a! 1%! (w/v)! agarose! gel! (Appendix! 1).! Two! microliters! (2! µL)! of! DNA! and! 5! µL! of!
Fermentas!1X!loading!dye!was!electrophoresed!at!80!mV!for!45!minutes.!
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on! the! NanoDrop!! ND51000! Spectrophotometer! using! the! NanoDrop!! 1000! computer!
software!(Appendix!2),!and!subsequent!dilutions!were!made!to!produce!working!samples!of!






To! ensure! that! specific! regions! containing! the! target! SNPs! are! amplified! during! PCR,!
oligonucleotide!primer!pairs!must!bind! to!particular! flanking! sequences!of!DNA!with!high!
fidelity.!The!500bp!reference!sequence!flanking!each!of!the!target!SNPs!in!MYH9!(rs5756129,!
rs11912763,!rs16996648,!rs5750248,!rs1557529,!rs8141189,!rs1005570,!rs16996672),!APOL1+
(rs73885319,! rs60910145! and! rs71785313)! and! HMOX1+ (rs3074372! and! rs743811)! was!










(http://www.ensembl.org/index.html)! using! their! respective! rs! numbers.! The! primer! pairs!
were!designed!manually!using!this!sequence.!!
The! properties! of! each! primer! pair! were! analysed! using! the! OligoAnalyzer! tool! v3.1!
(https://eu.idtdna.com/calc/analyzer),!specifically!the!GC!content!(%),!melting!temperature!
(°C),!and!the!free!energy!change!(#G,!kcal.mole51)!and!melting!temperature!(°C)!of!hairpin!
and! self5dimer! intramolecular! structures,! as! well! as! for! hetero5dimer! structures! formed!
between!primer!pairs.!The!PCR!product!size!was! limited!to!2005700bp!to!ensure!sufficient!
amplification! during! PCR,! and! allow! the! combination! of! specific! MYH9! primer! sets! in!
multiplex.!The!GC!content!preferably!ranged!from!40560%,!and!the!melting!temperature!was!








regions! in! the! human! genome! that! may! be! preferentially! amplified! during! PCR.!
Oligonucleotide! primer! pairs! that! met! all! the! criteria! for! the! target! SNPs! for! SNaPshot!







deletion! in!APOL1! (rs71785313,! referred! to!as!G2).! The! sequence!of! the!primers!used! for!
rs3074372!have!been!described!previously!(Kimpara!et!al.,!1997),!while!the!G2!primers!were!
manually! designed! from! the! Ensembl! sequence.! 65FAMTM! (Applied! Biosystems,! California,!
USA)! was! used! as! the! fluorescent! tag! for! rs3074372,! and! HEXTM! (Applied! Biosystems,!
California,!USA)!as!the!fluorescent!tag!for!rs71785313.!These!primer!sets!were!ordered!from!
! 40!
DNA! Synthesis! Service! at! UCT! (synthesized! using! the! Applied! Biosystems! 394! DNA!
synthesizer).!A!non5fluorescent! forward!primer! for! rs71785313!of! the!same!sequence!was!




4.2.),! rs16996648! (Table! 4.3.),! rs5750248! (Table! 4.4.),! rs1557529! (Table! 4.5.),! rs8141189!






















































































































































reaction,! consisting! of! repeated! thermal! cycling! intervals! of! DNA! denaturation,! primer!
annealing!to!its!complementary!DNA!sequence,!and!subsequent!Taq+polymerase5mediated!







The! necessary! conditions! to! facilitate! amplification! were! achieved! using! the! Bio5Rad!!
thermal! cycler! T100! TM! (Bio5Rad! laboratories,! Hercules,! CA,! USA).! The! thermal! cycling!
! 44!
conditions! included! an! initial! three!minute! denaturation! step,! typically! at! 95°C.! This! was!
succeeded!by!35!cycles!of!a!second!denaturation!step,!primer!annealing,!and!extension!at!















The!annealing! temperature! (Ta)! of! a! PCR! is! the! temperature! at!which! the!oligonucleotide!
primers!hybridize!to!the!target!template!DNA.!It!must!be!high!enough!to!inhibit!imperfect!and!
nonspecific! complementarity,! yet! low! enough! to! allow! sufficient! primer5template! DNA!









Electrophoretic! gels! for! the! resolution! of! SNPs! (A)! rs5756129! (324! bp),! (B)! rs11912763! (268! bp),! (C)!
rs16996648! (420! bp),! (D)! rs5750248! (579! bp),! (E)! rs1557529! (302! bp),! (F)! rs8141189! (478! bp),! (G)!
rs1005570!(671!bp),!and!(H)!rs16996672!(447!bp)!on!a!2%!(w/v)!agarose!gel.!SYBR!!Safe!DNA!Gel!Stain!



















































Electrophoretic!gels! for!the!resolution!of!SNPs!(A)!rs71785313!(384!bp),! (B)!rs60910145!(666!bp),! (C)!
rs73885319!(315!bp),!and!(D)!water!blanks!for!each!of!the!respective!SNPs!on!a!2%!(w/v)!agarose!gel.!
SYBR!! Safe! DNA! Gel! Stain! was! used! to! visualize! the! PCR! products! under! UV! light! on! the! UVIGold!
Transilluminator.!Lane!MWM!displays!the!GeneRulerTM100bp!Plus!DNA!molecular!weight!marker.!Lanes!























gradient! was! performed! from! 45°C555°C! (45.0°C,! 45.7°C,! 46.9°C,! 48.9°C,! 51.2°C,! 52.9°C,!
54.2°C,! 55°C)! (Figure! 9).! Rs8141189! displayed! preferential! amplification! of! the! target!




to! no! amplification! for! either! primer! set,! despite! repetition! of! the! reaction! to! ensure!
experimental!error!was!not!the!underlying!cause.!A!lower!temperature!gradient!of!48°C555°C!
(48°C,! 48.5°C,! 49.3°C,! 50.7°C,! 52.3°C,! 53.6°C,! 54.5°C,! 55°C),! and! doubling! of! the! primer!
concentrations!(final!concentration!of!20pm!per!reaction)!yielded!no!positive!results.!Next,!a!
MgCl2!gradient!(section!2.2.4.2)!was!performed!in!an!attempt!to!catalyse!the!incorporation!
of! dNTPs! to! initiate! amplification,! however! this! was! also! unsuccessful! in! producing! any!
amplicons!for!either!polymorphism.!KAPA2G!Fast!HotStart!(KAPA!Biosystems)!(Cape!Town,!
South!Africa!OR!Wilmington,!Massachusetts)!enzyme!offers!increased!processivity!and!speed!
of! reaction! in! comparison! to!wild5type! Taq! DNA! polymerase.! This! is! due! to! a! process! of!
directed! evolution!used! for!manufacturing! of! the! enzyme.! The! enzyme! is! supplied!with! a!
specially! formulated! buffer! (ReadyMix)! allowing! improved! specificity,! yield! and! overall!
reaction!efficiency.!Due!to!its!improved!robustness!in!comparison!to!normal!Taq,!the!KAPA2G!
Fast!HotStart!ReadyMix!was!used!in!the!optimization!procedures!in!an!attempt!to!encourage!
amplification! of! the! target! fragment.! The! ReadyMix! is! supplied! at! a! 2X! concentration!
containing! KAPA2G! Fast! HotStart! DNA! Polymerase,! dNTPs,! MgCl2! and! stabilizers! at! a!
concentration!of!0.5!U!per!25ul!reaction,!0.2!mM!at!1X!and!1.5!mM!at!1X,!respectively.!The!
reaction!was!optimized!using!50ng!of!control!DNA!template!(Sample!B8M!at!10ng/µl).!Cycling!
conditions!were! optimized! on! the! Bio5Rad!! thermal! cycler! T100TM! (Bio5Rad! laboratories,!
Hercules,!CA,!USA).!The!thermal!cycling!conditions,!as!specified!by!the!protocol,!included!an!




for! 1! minute.! Rs71785313! (APOL1)! and! rs3074372! (HMOX1)! displayed! large! amounts! of!
nonspecific!amplification!(Figure!7A!and!8A,!respectively),!particularly!at!lower!temperatures,!






58°C! (Temperature!3,! Figure!8),! respectively,!which!were! then! selected! for!use! in! further!
amplification!procedures.! Electrophoresis! of! rs73885319!displayed! ‘smearing’! surrounding!
the! target! region.!Reduction!of! the! cycle!number! to!30! cycles! in! comparison! to!35! in! the!

























































































necessary! for! resolution! of! the! independent! amplicons,! and! their! similar! annealing!















































are!enzyme!cofactors! that!enhance! the! incorporation!of! the! freely!available!dNTPs!during!
extension!of!the!oligonucleotide!primers.!High!concentrations!of!Mg2+!can!therefore!result!in!
imperfect! hybridization! of! the! primer! pairs! and! nonspecific! PCR! amplification,! while! low!
concentrations! of! the! cofactor! result! in! decreased! yield! of! the! target! amplicon,! possibly!




least! nonspecific! amplification! in! the! previous! temperature! gradient.! 1.0mM! at! pH! 8.3,!
2.5mM!at!pH!8.3!and!2.0mM!at!pH!8.6!were!the!only!MgCl2!buffer!parameters!that!amplified!
the!fragment!of!interest,!however!non5specific!amplification!was!still!abundant!and!therefore!


























nonspecificity! with! sufficient! amplification! of! the! target! region! (579! bp).! A! temperature!












































Betaine! acts! as! an! isostabilizing! agent! during! PCR! (Rees! et! al.,! 1993),! and! it! functions! to!
equalize!the!effect!of!AT5!and!GC5base!pairing!to!the!stability!of!the!DNA!duplex.!This!results!
in!an!increase!in!the!amplification!of!the!target!amplicon.!The!concentration!gradient!used!





































58.4°C! for! multiplex! C! (rs5756129,! rs8141189)! (Appendix! 3).! The! PCR! protocols! for!























Electrophoretic! gels! for! the! resolution! of! (A)! rs16996648! (420! bp),! (B)! rs5750258! (579! bp),! (C)!
Multiplex! A,! containing! rs1005570! (671! bp),! rs16996672! (447! bp)! and! rs73885319! (315! bp),! (D)!
Multiplex!B,!containing!rs1557529!(302!bp)!and!rs11912763!(268!bp)!and!(E)!Multiplex!C!containing!
rs5756129!(324!bp)!and!rs8141189!(478!bp)!on!a!(A,!B,!C,!E)!2%!and!(D)!2.5%!(w/v)!agarose!gel.!SYBR!!






















single! plex! D,! multiplex! A! and! multiplex! C! for!MYH9+ SNPs,! as! well! as! the! products! of!
amplification!for!fragment!analysis!(rs3074372!and!rs71785313),!and!direct!cycle!sequencing!
validation! (all! SNPs! excluding! rs3074372! (HMOX1))! were! prepared! to! 2%! (w/v)! using!
Seakem!LE!agarose!dissolved! in!1X!TBE!buffer! (Appendix!1).!Multiplex!B! required!a!2.5%!
(w/v)!gel!in!order!to!resolve!the!more!similarly!sized!fragments.!SYBR!!Safe!DNA!Gel!Stain!
(InvitrogenTM,! Thermo! Fisher! Scientific)! was! utilized! to! visualize! DNA! fragments.! Five!
microliters!(5!µL)!of!PCR!product!and!loading!dye,!respectively!(Appendix!1)!was!loaded!into!
the! gel.! The! DNA! loading! dye! contained! glycerol! to! increase! the! density! of! the! sample,!










To! facilitate! the! use! of! the! PCR! products! in! downstream! sequencing! reactions,! Thermo!
Scientific! FastAP! Thermosensitive! Alkaline! Phosphatase! (FastAP)! and! Exonuclease! I! (ExoI)!
clean5up!was!performed!on!all!PCR!products!(Appendix!1).!FastAP!removes!unincorporated!
dNTPs! through! dephosphorylation,! thereby! preventing! any! interference! in! downstream!
applications! such! as! sequencing,! while! ExoI! degrades! the! remaining! single5stranded! DNA!
molecules!and!oligonucleotide!primers,!preventing!the!need!for!further!purification!methods.!
The!final!reaction!volume!contained!1.5!units!and!2!units!of!FastAP!and!ExoI,!respectively,!
with!Sabax!distilled!water!being!used! to!make!up! the! final! reaction!volume!to!25!µL.!The!
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SNaPshot!! sequencing! is! a! single! nucleotide! primer! extension! based! SNP! genotyping!
technique! that!utilizes! the! incorporation!of! a! fluorescently! labelled!dideoxyribonucleotide!












up! PCR! product! (section! 2.2.6.)! and! the! SNaPshot!! ready! reaction! mix! containing! the!
fluorescently!labelled!ddNTPs!required!for!SNP!genotyping,!AmpliTaq!!DNA!Polymerase!for!
single!nucleotide!extension!of! the!DNA5primer! template! in! the!5’! to! 3’! direction,! and! the!





denaturation,!primer!annealing!and!product!extension!at!96°C! for!10! seconds,!50°C! for!5!
seconds!and!60°C!for!30!seconds,!respectively.!SNaPshot!sequencing!was!not!performed!for!
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the! non5SCD! controls! and! non5SCD! ESKD! cohort! due! to! the! inaccuracy! of! this! genotyping!
method,! as! only! four! SNPs! out! of! the! nine! (rs11912763,! rs16996648,! rs1005570! and!
rs16996672)! were! successfully! genotyped! and! validated,! and! subsequently! considered!
pertinent!for!immediate!analysis.!Furthermore,!preliminary!analysis!indicated!no!significant!
association! with! crude! albuminuria,! thus!MYH9! genotyping! was! not! performed! for! the!
remaining!SNPs.!
Table!5:!Nucleotide!sequence!and!properties!associated!with!SNaPshot!!primers!designed!









































































































































SNPs! rs16996648! and! rs16996672! were! SNaPshot! sequenced! in! the! reverse! direction,!
therefore!their!genotype!results!represent!the!complementary!bases!to!those!found!on!the!
forward!strand.!Figure!20!shows!the!SNaPshot!genotype!results!for!patient!472!for!each!SNP.!



















(D)! rs16996672.!Dye5labelled!GeneScanTM!Liz120!was!used!as! the! size! standard! for! the! reaction.!The!

















on! the! ABI3130xl! (Applied! Biosystems).! This! technique! determines! the! length! of! the!
fragments,!of!which!the!expected!length!is!known,!allowing!determination!of!the!number!of!
















acts! to! stabilize! the! single! stranded!DNA!molecules,!while! GeneScanTM! ROX500! functions!
similarly!to!the!GeneRulerTM!100bp!DNA!ladder!(Section!2.2.5)!and!the!GeneScanTM!Liz120!
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size! standard! used! for! SNaPshot! sequencing! (section! 2.2.7.2.).! The! final! solutions! were!
denatured! at! 95°C! for! five! minutes! using! the! Bio5Rad!! thermal! cycler! T100TM! (Bio5Rad!























TaqMan!! is!a!SNP!genotyping!method!utilizing!differentially! fluorescently! labelled,!allele5




using!direct! cycle! sequencing! (section!2.2.10)! and!was! subsequently! genotyping!using! the!
TaqMan!!method.!The!assays!are!supplied!at!40X!working!stock!concentration!containing!
region5specific!PCR!primers,!as!well!as!two!MGB!probes!with!an!allele5specific!5’!fluorescent!





120! µl! using! TE! Buffer! (7M! Tris! and! 0.3M! EDTA,! pH! 7.3).! 2X! TaqMan!! Universal! PCR!
MasterMix!(Applied!Biosystems,!ThermoFisher!Scientific,!Warrington,!UK)!was!utilized!as!the!
buffer!to!facilitate!optimal!reaction!conditions.!The!final!reaction!volume!was!optimized!to!




with! optically! clear! adhesive! covers! (ThermoFisher! Scientific,! Warrington,! UK).! Thermal!
cycling!conditions!were!performed!on!the!Bio5Rad!CFX96!(Bio5Rad!laboratories,!Hercules,!CA,!
USA)! and! included! enzyme! activation! at! 95! °C! for! 10! minutes,! followed! by! 40! cycles! of!
denaturation! and! annealing/extension! at! 95°C! for! 15! seconds! and! 60°C! for! 1! minute,!
















































was! performed! by! an! independent! laboratory! (Central! Analytical! Facilities,! University! of!
Stellenbosch),! that! confirmed! the! SNP! genotyping! results! of! four! SNPs! (rs11912763,!
rs16996648,!rs11005570,!and!rs16996672).!Each!cycle!sequencing!reaction!comprised!5!µL!
of!the!cleaned5up!PCR!product!(Section!2.3.4.),!1X!BigDye!!dilution!buffer,!10!pmol!of!the!




succeeded! by! 30! cycles,! each! containing! sub5steps! of! fragment! denaturation,! primer!
annealing,!and!primer!extension!at!96°C!for!30!seconds,!50°C!for!15!seconds,!and!60°C!for!4!




an! electropherogram! of! the! nucleotide! sequence.! Subsequent! to! detection! and! data!
collection,! the! sequencing! results! were! analyzed! using! the! BioEdit!! software! program!
(version!7.0.5.2;!6/5/05).!
!
Validation! confirmed! the! SNP! genotyping! results! of! four! SNPs! in! MYH9! (rs11912763,!
rs16996648,!rs11005570,!and!rs16996672)!from!SNaPshot!sequencing!that!were!considered!
for!analysis.!SNaPshot!sequencing!of!rs73885319,!one!of!two!alleles!of!APOL1!G1,!was!not!





345! (rs16996648),!604! (rs11912763)!and!620! (rs1005570).! SNP! rs1005570!was! sequenced!
using! the! reverse! primer,! while! SNPs! rs11912763,! rs16996648! and! rs16996672! were!
sequenced!using!the!forward!primer.!Figure!25!displays!the!electropherograms!for!validation!



















primer,! while! the! other! SNPs! were! sequenced! using! the! forward! primers.! The! genotype! results!
showed!(A)!homozygosity!for!the!minor!allele!of!rs11912763,!(B)!homozygosity!for!the!major!allele!of!







































143’s! sequencing! result! against! the!whole! reference! sequence,! extracted! from!Ensembl!Genome!
Browser! website! (http://www.ensembl.org/index.html).! Rs73885319! and! rs71785313! were!
sequenced!using!the!reverse!primer,!while!rs60910145!was!sequenced!using!the!forward!primer.!The!
genotype! results! showed! (A)! homozygosity! for! the! minor! allele! of! rs73885319! (i.e.! GG),! (B)!




Direct! Cycle! sequencing! confirmed! the! results! acquired! previously! for! majority! of! the!
validated!samples.!Homozygotes!for!the!minor!allele!of!rs60910145,!as!identified!by!TaqMan!
SNP!genotyping,!were!not!validated!using!direct!cycle!sequencing.!This!may!be!due!to!the!
close! proximity! of! rs71785313,! a! 6bp! deletion! which! may! affect! binding! of! the! reverse!
TaqMan!! probe,! as! seen! in! figure! 27.! All! samples! identified! as! homozygotes! for! the!





Analysis! of! the! integrity! and! purity! of! the! DNA! indicated! that! all! the! samples! were!




and! HMOX1! (rs3074372),! and! TaqMan!! sequencing! of! the! remaining! SNPs! in! APOL1+
(rs73885319!and!rs60910145)!and!HMOX1!(rs743811).!!Direct!cycle!sequencing!of!a!subset!of!
the!cohort! for!all!polymorphisms!excluding! rs3074372!was!performed,!and!confirmed! the!
* 
** *** 

















































albuminuria,! eGFR,! age,! BMI,! systolic! blood! pressure,! diastolic! blood! pressure,! serum!
creatinine!and!the!hematological!indices!distributions,!we!log105transformed!the!data!in!an!
attempt! to! normalize! the! variables! in! order! to! obtain! the! quantitative! trait! used! in! the!





Spearman’s! test! of! correlation! was! performed! to! determine! the! relationship! between!
albuminuria! and! the! numerical! variables;! age,! hemoglobin! levels,! eGFR,! hematological!
indices,!and!serum!creatinine.!Pearson’s!correlation!coefficient,!the!parametric!equivalent!of!
Spearman’s! test! of! correlation,!was! performed! to! test! the! association! between! log(ACR),!
log(SBP),!log(DBP)!and!log(leukocytes)!with!other!non5numerical!variables.!The!Kruskal5Wallis!
test! was! performed! to! compare! the! difference! in! medians! between! albuminuria! and!
categorical!variables;!sex,!"5Thalassemia,!HBB+haplotype!cluster!and!MYH9!SNP!genotypes!




statistical! package! R! (version! 3.0.3,! The! R! foundation! for! statistical! computing,! Vienna,!
Austria)! were! employed! for! the! analysis! of! combined! APOL1+ G1/G2! variants,! HMOX1+
polymorphisms,!and!the!3.7!kB!alpha5globin!gene!deletion!with!the!development!of!ESKD!in!















































patients! !  15!(9523)! 2558! 413! <0.0001!Non5SCD!




Female! 203!(49.15)! !  413!
0.0005!
Male! 210!(50.85)! !  
Non5SCD!
controls!
Female! 51!(71.83)! !  71!











and! BMI! distributions!were! positively! skewed! in! the! SCD! cohort,! and! age!was! negatively!
skewed! in! the! non5SCD! controls! cohort! and! could! therefore! not! be! analyzed! under! the!
assumption!of!a!normal!underlying!distribution.!The!skewed!distributions!informed!the!use!






































































SCD! patients! presented! with! normocytic! anemia! with! higher! white! blood! cell! count! in!
comparison!to!the!non5SCD!controls!(Table!8).!
The!Benin!(73%;!n=510)!and!Cameroon!haplotypes!(21%,!n=144)!were!the!most!prevalent!per!
number!of! chromosomes! in! the!SCD!patient! cohort.! In! combination,! the!Benin/Cameroon!
haplotype! represented! 26.3%! (n=92)! and! the! Benin/Benin! haplotype! 56%! (n=196)! of! the!
patient!cohort.!
Table!8!displays!descriptive!statistics! for! the!hematological! indices!of! the!SCD!patient!and!
non5SCD! control! cohort! for! whom! data! was! available.! The! non5parametric! spearman’s!
correlation! coefficient! test! was! performed! to! determine! the! relation! between! the! mean!
corpuscular!volume!(MCV)!of!red!blood!cells!with!albuminuria,!while!a!Pearson’s!correlation!









































patients! 7.5!(6.758.4)! 3.5!5!3090.5! 407!
Non5SCD!
controls! 13!(11.6514.6)! 8.1518.7! 71!
MCV!(fl)!
SCD!
patients! 85!(78592)! 605117! 413!
Non5SCD!
controls! 81!(76.5584)! 565102! 71!
MCHC!(g/dL)!
SCD!
patients! 33.5!(31.6535.5)! 21.5554.3! 413!
Non5SCD!
controls! 36!(32.3537.7)! 29.8545.2! 70!
WBC!(10^9/l)!
SCD!
patients! 12.7!(10.2516.2)! 4549.8! 413!
Non5SCD!
controls! 5.03!(4.555.9)! 2510! 71!
Lymphocytes!(10^9/l)!
SCD!
patients! 5!(3.8!5!6.7)! 1.4!5!22.1! 406!
Non5SCD!
controls! 2.2!(1.852.6)! 0.456.1! 71!
Monocytes!(10^9/l)!
SCD!
patients! 1.4!(0.952.1)! 0.158.2! 404!
Non5SCD!
controls! 0.6!(0.450.8)! 0.2594! 71!
Platelets!(10^9/l)!
SCD!
patients! 370!(2845466)! 29!5!1078! 402!
Non5SCD!
controls! 242!(181.55290.5)! 735651! 71!
HbA2!(%)!
SCD!
patients! 3.6!(2.85!5!4.1)! 0518.2! 408!
Non5SCD!
controls! 3.2!(253.9)! 0.155! 66!
HbF!(%)!
SCD!
















Figure! 31:! Scatter! plots! illustrating! the! relationship! between! hematological! indices! and! crude!
albuminuria! in! the! SCD! cohort,! with! a! significant! positive! relationship! observed! between! (A)! MCV!
(r=0.1667,!p=0.008)!and!(B)!log(Leukocytes)!(r=0.1160,!p=0.0202)!with!crude!albuminuria.!The!(A)!MCV!












the!distribution!of! eGFR! values! calculated!using! the! various! equations.!All! three! variables!
were!not!normally!distributed!despite!log!transformation!(Shapiro5Wilkes!test!p5value<0.05).!
This! informed! the! use! of! non5parametric! statistical! analysis,!with! figure! 33! displaying! the!



















MDRD! 140.5!(101.45205.5)! 44.65779.2! 214!(52.97)! 404!
Cockcroft5Gault! 111.8!(90.55162)! 55.15368.7! 172!(42.57)! 404!





































































































and!macro5albuminuria,! as!defined!by! the!ACR!value,!was!73.4%! (n=116)! and!5.1%! (n=8),!
respectively.! The! youngest! patient! to! display! micro5albuminuria! as! defined! using! crude!
albuminuria!was! four!years!old.!Based!on! the!CKD5EPI!equation,!34.2%! (n=67)!of!patients!
developed!hyperfiltration!alone,!while!61.7%!(n=121)!and!4.1%!(n=8)!displayed!associated!
micro5!and!macro5albuminuria,!respectively.!!
Figure!34:!Histogram!distribution!of! the!prevalence!of!hyperfiltration! in!various!age!groups! in! the!SCD!














































not! normally! distributed,! despite! log! transformation! (Shapiro5Wilkes! test! for! normality;!




The! distribution! of! the! ACR! data! was! positively! skewed! (Figure! 37A),! and! subsequently!














































per! age! group.! Albuminuria! was! reduced! in! older! patients! due! to! the! low! number! of!
individuals!in!the!three!oldest!age!group!(n=7,!n=6!and!n=5,!respectively).!This!is!also!likely!






































































































ratio!(ACR)!(mg/mmol)! 7.16!(3.4512.5)! 0.45236.5! 152!
Crude!albuminuria!
(mg/ml)! 41!(23583)! 351180! 407!
eGFR!(MDRD)!
(ml/min/1.73m2)! 140.5!(101.45205.5)! 44.65779.3! 404!
eGFR!(CKD5EPI)!
(ml/min/1.73m2)! 135.1!(1125154.4)! 50.85250.8! 404!
eGFR!(Cockcroft5Gault)!







































Neither! the! albuminuria! nor! eGFR! variables! were! normally! distributed,! despite! log!
transformation.! The! non5parametric! spearman’s! coefficient! was! therefore! calculated! to!















































(figure! 45).! Results! of! the! Wilcoxon! Rank! sum! test! indicated! that! eGFR! values! were!















































program! (version! 14.0.370! for! Windows).! Spearman’s! correlation! test! was! performed! to!
investigate! the! significance! of! the! relationships! between! crude! albuminuria,! and! age! and!
hemoglobin!levels!in!the!SCD!patient!cohort.!A!Kruskal5Wallis!test!was!employed!to!determine!
the!significance!of!the!relationship!between!crude!albuminuria!and!sex.!Age!was!significantly!
associated!with! increased!crude!albuminuria! in!SCD!patient! cohort! (r=0.1421,!p!=!0.0041)!





















































































13)! and! along! with! the! non5SCD! control! cohort,! genotyped! for! rs3074372! (HMOX1)! and!
rs71785313! (APOL1)! (figure! 49)! using! fragment! analysis,! and! for! rs733885319! (APOL1),!
rs60910145! (APOL1)! and! rs743811! (HMOX1)! (figure! 50)! using! TaqMan!! SNP! genotyping!
(Table! 14).! The! results! of! genotyping! of! targeted! variants! in!MYH9! for! SCD! patients! are!




























































































































































































































































Table! 15:! The! minor! allele! frequencies! (MAF)! of! rs11912763,! rs16996648,! rs1005570,!






























0.156! 0.23! 0.385! 0.262! 0.156! 0.221! 0.221!
Esan!
(Nigeria)! 0.399! 0.49! 0.591! 0.419! 0.162! 0.495! 0.495!
Yoruba!
(Kenya)! 0.324! 0.407! 0.5! 0.37! 0.120! 0.375! 0.375!
Europe! 0.001! 0.021! 0.101! 0.002! 0.253! 0! 0!







three! times! greater! than! that! of! the! Cameroonian! cohort,! and! there! was! no! similarity!
between!the!MAF!of!each!of!the!SNPs!in!the!Cameroonian!cohort!compared!to!the!European!




















Our6cohort6 (Cameroon) African6American6(Southwest6US) Esan6(Kenya) Yoruba6 (Nigeria) Europe East6Asia
Figure!54:!Comparison!of!MAF!of!MYH9!SNPs!between!various!populations.!
Bar!graph!comparing! the!minor!allele! frequencies! (MAF)!of!MYH9! SNPs! rs11912763,! rs16996648,!







cohort! (0.13),! non5SCD! ESKD! case! cohort! (0.146)! and! the! non5SCD! ESKD! control! cohort!



























SCD-patient-cohort- (Cameroon) NonMSCD-control-cohort- (Cameroon) ESKD-case-cohort- (Cameroon)
ESKD-control-cohort- (Cameroon) African-American-(Southwest-US) Esan-(Nigeria)
Yoruba- (Kenya) Europe East-Asia
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No!MAF!data!is!available!for!the!HMOX1!rs3074372!and!APOL1+G2!(rs71785313)!variants!in!
various! world! populations.! Figures! 54! and! 55! therefore! display! the! frequency! of! the!
genotypes!for!the!respective!variants! in!our!Cameroonian!SCD!patients,!non5SCD!controls,!
non5SCD!ESKD!cases!and!non5SCD!ESKD!controls.!The!S/S!genotype!for!HMOX1+rs3074372!was!






















































The! Kruskal5Wallis! test! was! also! performed! to! determine! the! nature! of! the! relationship!
between!the!3.7kB!"5globin!gene!deletion!genotype!and!crude!albuminuria,!also!displaying!a!
non5significant!relationship!in!the!SCD!patient!cohort!(p=0.541).!







































































































































SCD! patient! cohort;! crude! albuminuria,! macro5albuminuria,! ACR,! and! the! estimated!
Glomerular!Filtration!Rate!(eGFR),!calculated!using!three!equations;!CKD5EPI,!MDRD!and!CGN.!






















































































































model! (p=0.01829).! APOL1! therefore! holds! potential! to! anticipate! early! development! of!
kidney!disease!in!the!context!of!SCD,!which!likely!has!a!selective!association!with!these!SNPs!
in! comparison! to! the! general! population.! The! association! of! APOL1! G1/G2! with! the!
development! of! macro5albuminuria! approaches! significance! in! a! recessive! model!
(p=0.08537).!The!association!of!APOL1+G1/G2!tends!to!significance!with!eGFR!calculated!using!
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The! HMOX1! dinucleotide! promoter! polymorphism! (rs3074372)! showed! no! significant!
association!with!crude!albuminuria,!macro5albuminuria,!or!increased!ACR!levels!in!the!SCD!
cohort! (Figure! 60).! Furthermore,! no! significant! association! with! eGFR!was! observed.! The!
HMOX1+ SNP! (rs743811)! tends! to! a! significant! association! with! crude! albuminuria! in! a!
codominant!(p=0.07372)!and!recessive!(p=0.08013)!model!(Figure!61),!as!well!as!with!macro5
albuminuria!in!a!recessive!model!(p=0.0629),!but!shows!no!significant!association!with!ACR!
(p=0.6159),! despite! log! transformation! (p=0.8455).! A! near! significant! association! was!
observed!with!eGFR!calculated!using!the!MDRD!equation!in!a!codominant!(p=0.09865)!model.!!
!
The! 3.7! kB! alpha5thalassemia! deletion! displayed! no! significant! association! with! crude!
albuminuria!or!ACR!data,!however! it!was!significantly!associated!with!the!development!of!














!Box! and! whisker! plots! illustrating! the! distribution! of! (A)! crude! albuminuria,! (B)! ACR! and! (C)! eGFR!
(calculated!using!the!CKD5EPI!equation)!values!conditioned!on!the!APOL1!G1/G2!polymorphism,!based!








































































Figure! 60:! Box! and! whisker! plots! showing! the! association! of! HMOX1+ S/L! Genotypes! with! crude!
albuminuria!and!ACR!values!in!the!SCD!patient!cohort.!
!Box! and! whisker! plots! illustrating! the! distribution! of! (A)! crude! albuminuria! and! (B)! ACR! values!
conditioned!on!the!HMOX1+rs3074372!genotype!based!on!the!presence!of!short!(S,!≤25)!or!long!(L,!>25)!
















































!Box! and! whisker! plots! illustrating! the! distribution! of! (A)! crude! albuminuria! and! (B)! ACR! values!














































































(p=0.07).! The! dinucleotide! promoter! polymorphism! of! HMOX1! (rs3074372)! displayed! no!
association!with!any!early!indicator!of!renal!dysfunction!in!SCD!patients,!however!rs743811!
(HMOX1)! tended! to!a! significant!association!with!eGFR!values! calculated!using! the!MDRD!
equation!(p=0.09)!in!the!SCD!cohort.!The!co5inheritance!of!alpha5thalassemia!was!significantly!



























Characteristic! Cases!(n=167)! Controls!(n=162)! pPvalue!




















































obtained! from! the! chi5squared! test! for! deviation! from! Hardy5Weinberg! equilibrium! is!
displayed!for!each!SNP,!as!well!as!the!p5value!obtained!from!the!test!of!association!between!




































































































ESKD! in! a! recessive! genetic! model! (p=0.014),! while! G2! was! not! (p=0.2847).! The!HMOX1!
dinucleotide!promoter!polymorphism!was!significantly!associated!with!the!development!of!
ESKD! in! a! codominant! (p=0.0020401),! dominant! (p=0.0005690),! and! overdominant!
(p=0.0049646)! model,! with! a! recessive! model! (p=0.0634278)! approaching! significance.!









matched! control! group! consisted! majorly! of! adult! patients! (52! [46559]! and! 54! [47561],!
respectively).! There!was! no! significant! association! between! the!APOL1! G1/G2! variants! or!
rs743811! (HMOX1)! and! the! development! of! ESKD! in! our! Cameroonian! cohort,! however!
analysis!of!APOL1!G1!alone!produced! identified!a!significant!association!with!non5diabetic!
CKD! in! this! group! of! Cameroonian! patients.! On! the! contrary,! the! dinucleotide! promoter!











heterozygosity! for! APOL1+ G1/G2! and! variants! in! HMOX1! in! African! SCD! cohorts! from!




with!micro5albuminuria! that! increased!with! age,! as! well! as! a! high! proportion! of! patients!
presenting!with!hyperfiltration!as!evaluated!by!eGFR!values,!that!decreases!with!age!and!was!
higher!among!males.!The!study!also!provides!and!confirms!important!clinical!predictors!of!










exists! among! African! populations! (Gurdasani! et! al.,! 2015),! that! in! this! specific! case! is!
confounded! and! greatly! influenced! by! various! trypanosome! endemicity.!Moreover,! these!
results!indicate!the!need!to!extend!the!study!with!further!genotyping!e.g.!using!whole!exome!
and!genome!sequencing! to! refine! the!genomic!architectures! in! target! regions! such!as! the!
MYH9,!APOL1!and!HMOX1!genes,!in!many!SCD!groups!from!various!regions!of!Africa.!This!will!
help! to! refine! and! define! appropriate! tagging! variants! for! micro5albuminuria! in! these!
populations.! The! comparison!with! a! non5SCD!group!of! older! patients!with! ESKD! indicates!
another!level!of!complexity!with!a!surprising!insignificant!association!between!APOL1+G1/G2!




population.!Alternatively,! these!preliminary! results! could! indicate! that! variants! in!HMOX1+
gene,!rather!than!APOL1,!are!more!prominently!associated!with!in!the!development!of!ESKD!
in! this! non5SCD!population! from! sub5Saharan!Africa.! Future! studies! require! larger! sample!
sizes!of!older!SCD!patient!populations,!as!well!as!complete!genotyping!within!the!non5sickle!
population!of!study,!such!as!alpha5thalassemia!and!HbS!carrier!status,!HMOX1,!APOL1,!and!
the! occurrence! of! kidney! disease.! Sickle! Cell! trait! (SCT)! is! associated!with! reduced! eGFR,!
increased! risk!of!CKD!and!albuminuria,! in! comparison! to!homozygotes! for!wild! type!adult!













Reid,! 2015).! Micro5albuminuria! is! preferred! to! proteinuria! measurement! due! to! difficult!
standardization!resulting!from!the!variable!composition!of!protein!in!the!urine!(Levey!et!al.,!
2013).! The! urine! albumin5to5creatinine! ratio! (ACR)! resulting! from! urine! albumin! and!
creatinine! measurement! in! an! untimed! urine! collection! is! the! preferred! approach! for!
detecting! the!presence!of! crude!albuminuria,! and! is! comparable! to! results! obtained! from!
albumin!excretion! rate! calculated! from! timed!urine! collections! (Eknoyan!and! Levin,! 2002;!
Levey!et!al.,!2013).!Micro5!and!macro5albuminuria,!as!defined!by!the!ACR!(Table!8,!Section!
3.2.2.)! were! present! in! 73.4%! (n=121)! and! 5.1%! (n=8)! of! the! patient! cohort! (n=158),!








adolescents! in! the!present! study.!However,!our! result! is! still! substantially!higher! than! the!
18.5%! and! 6.2%! prevalence! of! micro5albuminuria! and! proteinuria! among! Nigerian! and!
Congolese!children!with!SCD,!respectively!(Aloni!et!al.,!2014;!Eke!et!al.,!2012).!The!prevalence!
of! micro5albuminuria! in! our! cohort! is! also! higher! compared! to! previous! results! of! 19%!




albuminuria! in!SCD!patients! (Alvarez!et!al.,! 2006;!Mawanda!et!al.,! 2011;!McBurney!et!al.,!
2002),!thus!may!act!to!increase!the!prevalence!of!micro5albuminuria!in!our!cohort.!In!African5




employed! in! the! design! of! the! study! that! could! have! favored! the! recruitment! of! sicker!
individuals.! A! high! proportion! (63.6%)! of! micro5albuminuria! was! equally! observed! in! a!
population! of! hospital5based! SCD! patients! in! Saudi! Arabia! (Abo5Zenah! et! al.,! 2009).! The!
distribution!of!median!albuminuria!values!per!age!group!in!our!SCD!cohort!(figure!38,!section!








their! genetic! constitution,! and! it! could! therefore! be! unsurprising! that! the! older! patients!
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2003).! Glomerular! hyperfiltration,! defined! as! an! estimated! filtration! rate! >130!
ml/min/1.73m2! and! >140!ml/min/1.73m2! in!women!and!men,! respectively,! in! accordance!
with!previous!studies!of!SCD!cohorts!(Haymann!et!al.,!2010;!Hirschberg,!2010;!Vazquez!et!al.,!
2014),!was!prevalent!in!52.97%!(n=214),!42.57%!(n=172)!and!49.5%!(n=200)!of!the!SCD!cohort!
based! on! calculations! using! the!MDRD,! CG! and! CKD5EPI! calculations,! respectively.! This! is!
comparable!with!previous!prevalence!rates!of!51%,!53.1%!and!41.5%!in!adolescent!French,!







Gault!equation,!despite! its! systemic!overestimation!of!GFR!values! (Haymann!et!al.,!2010).!
Recent! studies! contradict! these! findings! through! identification! of! the! CKD5EPI! equation,!







eGFR!values,!with! the! recommendation! that!a!new!adjusted!Schwartz!equation!offers! the!










The! study! also! validated! the! significant! positive! association! of! crude! albuminuria! with!
increasing!age,!as!previously!reported!in!American!(Guasch!et!al.,!2006;!Saraf!et!al.,!2014)!and!
Nigerian! patients! (Eke! et! al.,! 2012).! Furthermore,! this! study! indicates! a! hyperfiltration!
prevalence!based!on!eGFR!values!among!SCD!patients!in!Cameroon!comparable!to!those!of!
French! (51%)! adult! Nigerian! (30.6%),! adult! sub5Saharan! African! and! French! West! Indian!
natives!(53.1%),!respectively!(Arlet!et!al.,!2012;!Bolarinwa!et!al.,!2012;!Haymann!et!al.,!2010).!
Crude! albuminuria! displayed! a! near! significant! association! with! reduced! hemoglobin!
(p=0.0691),!while! increased!BMI! (p=0.0489),! leukocyte! (p=0.0202),!mean!arterial! pressure!




MCV! of! erythrocytes,! and! exerts! a! protective! effect! against! the! development! of! macro5





increased!white! blood! cell! counts! and! higher!MCV’s!were! significant! clinical! indicators! of!
impending!kidney!disease!(Asnani!et!al.,!2011;!Wigfall!et!al.,!2000).!We!did!not!observe!the!
significant!association!between!rising!blood!pressure!(p=0.06659!for!SBP,!p=0.6679!for!DBP)!
and! increased! albuminuria! seen!previously! (Asnani! et! al.,! 2016;!Aygun! et! al.,! 2011),! even!
though! a! significant! association! was! observed! between! ACR! values! and! increased! SBP!
(p=0.0217),!however!not!with!DBP!(p=0.6902).!No!significant!association!with!albuminuria!
and! serum! creatinine! (p=0.2951)! was! observed,! similar! to! previous! reports! in! African!
American! children! with! SCD! (Wigfall! et! al.,! 2000).! Our! results! showed! no! significant!
! 139!
association!between!albuminuria!and!hyperfiltration,!contrary! to!previous!reports! in!adult!
SCD! patients! (Arlet! et! al.,! 2012;! Thompson! et! al.,! 2007),! which! may! be! due! to! the! high!
prevalence! of! children! and! adolescents,! with! consequent! low! proportions! of! macro5







and! Reid,! 2015;!M.! Asnani! and! Reid,! 2015),! further! supporting! the! fact! that! the! state! of!
hyperfiltration! is!an!early!pathology! in!those! likely!to!decline!to!CKD.!Vazquez!et+al+(2014)!
have!similarly!described!increasing!rates!of!micro5albuminuria!development!with!increasing!
levels!of!hyperfiltration.!The!surprising!positive!association!of!albuminuria!with!GFR!was!also!
recently! shown! in!a!prospective! longitudinal! study! (Asnani!et!al.,!2016).!Nevertheless,! the!
contradictory!findings!between!micro5albuminuria!and!ACR!with!declining!eGFR,!as!reported!
in!the!present!study,!indicate!the!need!for!a!prospective!cohort!study!to!unravel!the!role!of!
albuminuria! as! a! predictor! of! GFR! and! the! progression! of! sickle! glomerulopathy! and!
worsening!CKD,!in!SCD.!
!
Glomerular! filtration! rate,! another! early! indicator! of! renal! dysfunction,! was! increased! in!
younger! patients,! however! reduced! with! increasing! age! (p<0.0001),! similar! to! previous!
reports!(Aygun!et!al.,!2011;!Wigfall!et!al.,!2000).!Other!studies!have!also!indicated!increasing!
albumin! excretion! with! increasing! age! (Asnani! et! al.,! 2016,! 2011;! Guasch! et! al.,! 2006;!
Thompson!et!al.,!2007).!Renal!functional!decline!with!age!is!anticipated!in!individuals!with!
HbSS!disease,!and! is!one!of! the!most! common!causes!of!morbidity!and!mortality! in!older!
adults!with!SCD,!with!the!annual!rate!of!decline!in!GFR!estimated!to!be!3.2!ml/min/1.73!m2!
















association! of! hemoglobin! with! estimated! GFR,! reported! here! reflects,! as! previously!
speculated! by! previous! studies,! the! relationship! between! hemoglobin! and! elevated! eGFR!
values! (Asnani! et! al.,! 2016;! Haymann! et! al.,! 2010).! Worsening! anemia! is! known! to! be!
associated!with!renal!insufficiency!in!sickle!and!non5sickle!populations!(Norris,!2006;!Powars!










3.2.).! The!MAF! in! the! Yoruban! and! Esan! populations! (0.324! and! 0.399,! respectively)! was!






times! greater! in! European! (0.25)! and! Asian! (0.66)! populations,! respectively.! In! addition,!
European! and! Asian! populations! from! the! 1000G! displayed! no! presence! of! the! APOL1!
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rs73885319! and! rs60910145! minor! allele,! validating! hypotheses! that! these! variants!






are! believed! to! have! been! selected! by! affording! protection! from! Trypanosoma+ brucei+




that! the!APOL1+ variants! arose! in! sub5Saharan! Africa,! likely!West! Africa! (Genovese! et! al.,!
2010a),!with!results!from!the!Yoruban!population!in!Nigeria!from!the!1000G!project!providing!
convincing!evidence!of!a!selective!sweep!in!these!regions.!Indeed,!the!APOL1!G1/G2!alleles!






within! Africa! (Gurdasani! et! al.,! 2015),! substantiating! the! need! for! increased! research! in!








of!26,! and!89%! (n=62)!prevalence!of! adults.! The!young!age!of! this! selected!group!of! SCD!
patients!could!be!an!indirect!indicator!of!the!poor!survival!rates!of!SCD!patients!in!Cameroon.!
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Previous! studies! have! shown! an! association! of! homozygous! or! compound! heterozygous!
APOL1+G1/G2!variants!with! kidney!disease! in! adult! patients! living!with! sickle! cell! disease,!
possibly!through!increased!risk!of!hemoglobinuria,!and!associations!of!HMOX1!variants!with!
kidney! disease,! possibly! through! reduced! protection! of! the! kidney! from! hemoglobin5
mediated!toxicity!(Saraf!et!al.,!2015).!The!relatively!young!age!of!the!cohort!could!account!for!
a! lower!proportion!of! patients!without!macro5albuminuria! that!was!previously! associated!














of! podocytes! (Palmer! et! al.,! 2014).! A! single! report! found! that! individuals!with! the!APOL1!
G1/G2! risk! variants! (defined!as!being!homozygous!or! compound!heterozygous! for! the!G1!
and/or!G2!risk!variants!using!a!recessive!model)!were!3.45times!more!likely!to!have!dipstick5
defined! proteinuria! and! that! variants! in! MYH9+ were! independently! associated! with!
proteinuria!after!adjusting!for!APOL1+variant!status!(Ashley5Koch!et!al.,!2011).!Furthermore,!
a!significant!interaction!between!the!APOL1+G1/G2!risk!variants!and!a!MYH9!risk!haplotype!














The! G1! and! G2! alleles! of! APOL1+ are! mutually! exclusive,! never! occurring! on! the! same!
chromosome! and! have! comparable! effect! sizes! for! kidney! disease,! therefore! their!
independent! frequencies! can!be! combined! to!determine! the!burden!of! risk! variants! for! a!
particular! cohort! (Genovese! et! al.,! 2010b;! Kopp!et! al.,! 2011).!A! significant! difference!was!
observed!with!homozygosity!or! compound!heterozygosity! for!APOL1+G1/G2!between!SCD!
patients!and!the!non5SCD!control!cohorts!(p=0.0097),!which!could!tend!to!indicate!a!selective!
force! and! enrichment! of! favorable! and! protective! alleles! among! SCD! patients.! We! have!
previously! shown! such! a! trend! for! the! 3.7! kB! alpha5thalassemia! deletion! which! has! a!
proportion!that!is!double!in!SCD!patients!compared!to!non5sickle!Cameroonian!controls,!likely!
a! result! of! its! association! with! improved! hematological! indices,! protective! effect! against!
stroke!or! kidney!disease,! and!possibly! increased! survival!of! SCD!patients! (Rumaney!et!al.,!
2014;!Wonkam!et!al.,!2014b).! Interestingly,!homozygosity!or!compound!heterozygosity!for!
APOL1+ G1/G2! displayed! a! significant! association! with! ACR! values! in! a! recessive! model!
(p=0.018)! in! the!present!study,!as!observed!previously! in!African!American!adult!patients,!
where! the! variants! displayed! a! prevalence!of! 14%! (Saraf! et! al.,! 2015).! In! addition,!APOL1+
G1/G2!tended!to!a!significant!association!with!increased!eGFR!as!calculated!using!the!CKD5
EPI!equation!(p=0.073)!in!a!recessive!genetic!model.!Moreover,!the!association!with!macro5
albuminuria! also! approached! significance! in! a! recessive! model! (p=0.085).! These! results!





et! al.,! 2007)! or! the! glomerular! filtration! rate! (Aygun! et! al.,! 2013)! in! SCD.! The! possible!
association! of!APOL1+G1/G2!with! eGFR! ! agrees!with! previous! studies! of! a! group! of! adult!
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patients! and! has! validated! the! CKD5EPI! equation! to! be! the! most! accurate! of! those! that!








ferrous! (Fe2+)! to! ferric! (Fe3+)! hemoglobin! (methemoglobin),!which! in! turn! readily! releases!
heme! into! the! vasculature,! and! subsequently! circulating! cell5free!hemoglobin! is! increased!
more! than! 105fold! in! SCD! patients! (Muller5Eberhard! et! al.,! 1968;! Naumann! et! al.,! 1971).!
Therefore,! intravascular! hemolysis! is! a! potential! cause!of! oxidative! injury! and! endothelial!
damage! in! SCD! (Gladwin! and! Sachdev,! 2012;! Nath! and! Katusic,! 2012;! Tracz! et! al.,! 2007).!
Exposing!human!proximal!tubular!cells!to! increasing!cell5free!hemoglobin! led!to! increasing!
concentrations! of! supernatant! kidney! injury! molecule,! reduced! viability! and! induction! of!







Saraf! et! al.,! 2015),! with! evidence! suggesting! that! lower! numbers! of! repeats! have! higher!
inducible!heme!oxygenase!expression!levels!and!a!subsequent!protective!effect!in!the!face!of!
increased! hemolysis! (Hirai! et! al.,! 2003;! Kimpara! et! al.,! 1997;! Taha! et! al.,! 2010).! The!








hospitalization! for! acute! chest! syndrome! consistent! with! the! shorter! GT5tandem! repeat!
length! polymorphism! having! a! protective! association! in! SCD! (Bean! et! al.,! 2012),! and!will!
deserve!further!investigation!in!Africa.!
!
However,! in! the! present! report,! the! SNP! in! HMOX1+ (rs743811)! tended! to! a! significant!
association!with!crude!albuminuria!in!a!codominant!(p=0.07372)!and!recessive!(p=0.08013)!
model!in!the!SCD!cohort,!as!well!as!with!macro5albuminuria!in!a!recessive!model!(p=0.0629).!
Moreover,! the! SNP! in!HMOX1+ (rs743811)! displays! a! near! significant! association!with!GFR!
























1999),! Tanzania! (58%)! (Cox! et! al.,! 2013),! and! in! the!USA! among!African!Americans! (41%)!
(Guasch!et!al.,!1999).!The!3.7kB!"5globin!gene!deletion!was!also!significantly!deviated!from!









patient! chromosomes! (n=510),! that! is! also! associated! with! a!milder! and!more!moderate!
course!of!SCD!(Steinberg!et!al.,!1998),!No!significant!differences!between!the!HBB+haplotypes!

























hypertension5attributed! ESKD! (Genovese! et! al.,! 2010a;! Kopp! et! al.,! 2011).! Studies! in! a!
Nigerian! population! of! non5sickle! patients! with! non5diabetic! CKD! indicated! a! significant!
association!with!APOL1+G1!variant!(Tayo!et!al.,!2013).!Our!lack!of!reproducible!results!may!be!
due! to! insufficient! statistical!power!as!a! result!of! small! sample! size!used! in!Cameroon,!as!
analysis!of!only!the!patients!successfully!genotyped!for!all!three!variants!constituting!APOL1+
G1/G2! was! performed! (n=242).! The! lower! MAF! of! APOL1+ G1/G2! variants! seen! in! our!
Cameroonian! cohort! in! comparison! to! the! Nigerian! population! indicates! the! need! for!
increased!sample!sizes!of!Cameroonian!patients.!This!result!may!also!indicate!that!the!APOL1!
G1/G2!variants!have!a!lesser!association!with!ESKD!in!non5diabetic!patients!(compare!to!e.g.!
HMOX1! variants! in! the! present! study)! and! do! not! have! the! same! effect! in! Africans! as!
previously!reported!in!African!American!patients,!as!this!could!be!dependent!on!APOL1!G1/G2!
MAF,!as!well!as!past!and!present!trypanosomiasis!endemicity,!as!discussed!earlier!(Limou!et!
al.,! 2014).! In! the! context! of! Africa,! where! Trypanosoma+ brucei+ gambiense! is! not! equally!
common!in!all!the!regions!as!it!is!in!Cameroon,!the!frequency!of!the!protective!allele!may!be!
















Micro5albuminuria’s! association!with! increasing! age! substantiates! the! prevalence! of! renal!
dysfunction!in!older!SCD!patients.!Furthermore,!the!selective!and!protective!effect!of!the!co5
inheritance! of! alpha5thalassemia! with! macro5albuminuria! in! the! context! of! SCD! was!
replicated.! The! unique! finding! of! the! present! research! that! have! shown! a! significant!
association! of! APOL1+ G1/G2! variants! with! ACR! suggests! the! possible! utility! of! these!




kidney!dysfunction!of!various!etiologies! in! individuals!of!African!descent! (Genovese!et!al.,!
2010a;!Kasembeli! et! al.,! 2015a;!Kopp!et! al.,! 2011;! Saraf! et! al.,! 2015).! The!near! significant!
association!of!APOL1+G1/G2!and!rs743811!with!eGFR,!another!early!indicator!of!glomerular!
dysfunction,! requires! further! investigation! into! their! utility! as! markers! for! screening!









In!addition! to! clinical! factors!used! to!predict! the!development!of! sickle!nephropathy,! it! is!













could! have! allowed! disproportionate! enrollment! of! sicker! patients! presenting! micro5






the! analysis! of! the!APOL1! variants! and! their! association!with! the! development! of! kidney!















of!kidney!disease! in!SCD!patients.!These!results! indicate! the!potential!of!selected!variants!
such! as! APOL1+ G1/G2! and! HMOX1+ rs743811! to! be! used! to! identify! patients! at! risk! for!
development!of!early!indicators!of!kidney!disease,!such!as!micro5albuminuria!and!glomerular!
hyperfiltration,! while!MYH9+ SNPs! and! the! HMOX1+ dinucleotide! promoter! polymorphism!
(rs3074372)! may! be! unsuitable! to! detect! any! early! stage! of! renal! impairment! in! a!
Cameroonian! SCD! population.! HMOX1+ rs3074372,! however,! is! associated! with! the!
development! of! ESKD! in! the! general! Cameroonian! population!with! various! comorbidities,!
implying! that! genetic! polymorphisms! may! contribute! to! the! development! of! kidney!

































































































































































































































































































































































































































































































































































































































































































































































































































































Range: 15 to 120 bp under denaturing conditions
This single-stranded size standard was designed to provide accurate sizing of short 
DNA fragments. Therefore, it is particularly useful for SNP analysis. All fragments 
have been optimized under a wide variety of run conditions.
Figure 8  GeneScan™ 120 Size Standard run under denaturing conditions
GeneScan™ 
500 LIZ® Size 
Standard
Range: 35 to 500 bp under denaturing conditions
This size standard is recommended for analysis of tri- and tetranucleotide 
microsatellite loci, which can often exceed 400 bp in length. 
Only one strand of the double-stranded DNA fragments in this size standard is 
labeled. The unlabeled strand does not interfere with peak detection of the labeled 
strand when run under denaturing conditions.




GeneScan™ 500 LIZ® denatured fragment lengths (nt): 16 fragments
35 139 250†
† Do not use this fragment for sizing. See “Peaks not used for sizing” on page 43 for information.
400
50 150 300 450
75 160 340 490






















































Sabax!distilled!H2O! ! ! 16.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
Forward!Primer! 20!µM! 10!pM! 0.5!
Reverse!Primer! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100ng/µL! 100!ng! 1!





























Sabax!distilled!H2O! ! ! 16.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
Forward!Primer! 20!µM! 10!pM! 0.5!
Reverse!Primer! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100ng/µL! 100!ng! 1!

































































Sabax!distilled!H2O! ! ! 14.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
DMSO! 100%! 8%! 2!
Forward!Primer! 20!µM! 10!pM! 0.5!
Reverse!Primer! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100ng/µL! 100!ng! 1!

















































Sabax!distilled!H2O! ! ! 14.4!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1.5!
Forward!Primer!
(rs1005570)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs1005570)! 20!µM! 10!pM! 0.5!
Forward!Primer!
(rs16996672)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs16996672)! 20!µM! 10!pM! 0.5!
Forward!Primer!
(rs73885319)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs73885319)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100ng/µL! 100!ng! 1!




































Sabax!distilled!H2O! ! ! 15.4!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1.5!
Forward!Primer!
(rs1557529)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs1557529)! 20!µM! 10!pM! 0.5!
Forward!Primer!
(rs11912763)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs11912763)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100ng/µL! 100!ng! 1!




















































Sabax!distilled!H2O! ! ! 14.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!Mm! 200!µM! 1.5!
Betaine! 5M! 0.1M! 0.5!
Forward!Primer!
(rs5756129)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs5756129)! 20!µM! 10!pM! 0.5!
Forward!Primer!
(rs8141189)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs8141189)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 100!ng/µL! 100!ng! 1!






















































Sabax!distilled!H2O! ! ! 8.7!
KAPA2G!Fast!HotStart!
ReadyMix! 2X! 1X! 10!
Forward!primer! 20!µM! 10!pM! 0.4!
Reverse!primer! 20!µM! 10!pM! 2.4!
Template!DNA! 10!ng/µL! 5!ng! 0.5!






































Sabax!distilled!H2O! ! ! 11.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
Forward!Primer!
(rs73885319)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs73885319)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 10!ng/µL! 50!ng! 5!























































Sabax!distilled!H2O! ! ! 11.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
Forward!Primer!
(rs60910145)! 20!µM! 10!pM! 0.5!
Reverse!Primer!
(rs60910145)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 10!ng/µL! 50!ng! 5!







































Sabax!distilled!H2O! ! ! 11.9!
GoTaq!!Buffer! 5X! 1X! 5!
dNTPs! 5!mM! 200!µM! 1!
Forward!Primer!
(rs743811)! 20!µM! 10!pM! 0.5!
Reverse!Primer!(rs743811)! 20!µM! 10!pM! 0.5!
GoTaq!!DNA!Polymerase! 5!U/µL! 0.02!U/µL! 0.1!
Template!DNA! 10!ng/µL! 50!ng! 5!








































Sabax!distilled!H2O! ! ! 6!
SNaPshot!!Primer! 20!µM! 2!µM! 1!
SNaPshot!!mix! ! ! 0.5!
PCR!Product! 100ng! 10ng! 2.5!





























































MasterMix! 2X! 1X! 5!
TaqMan!!Assay!Working!
stock! 20X! 1X! 0.5!
Sabax!distilled!H2O! ! ! 2.5!
Template!DNA! 10!ng/µL! 20!ng! 2!
+ ! Total:! 20!
!
Cycling!conditions:!Performed!on!the!BioRad!CFX96!
! !
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APPENDIX!6:!DIRECT!CYCLE!SEQUENCING!
!
Steps!performed!to!prepare!the!samples!for!capillary!electrophoresis!subsequent!to!the!
direct!cycle!sequencing!reaction.!
!
1.! Added!two!microliters!(2!µL)!of!sodium!acetate!(Appendix!1)!and!2.5X!the!total!
sample!reaction!volume!of!absolute!ethanol!(100%)!to!each!sample.!
2.! The!samples!were!vortexed.!
3.! Samples!were!left!at!520°C!overnight.!
4.! The!following!day,!the!samples!were!centrifuged!at!10!000g!for!ten!minutes.!
5.! Discarded!the!supernatant.!
6.! A!volume!of!2.5X!the!reaction!volume!of!70%!ethanol!(100%!ethanol!diluted!with!
distilled!water)!was!added!to!each!sample.!
7.! The!samples!were!vortexed.!
8.! Centrifuged!samples!at!10!000g!for!ten!minutes.!
9.! Discarded!the!supernatant.!
10.!Samples!were!left!to!air5dry!for!six!hours.!
11.!Once!dry,!the!samples!were!resuspended!in!10!µL!Hi5DiTM!Formamide.!
12.!Five!microliters!(5!µL)!of!the!sequencing!product!was!added!in!combination!with!8!
µL!Hi5DiTM!Formamide!to!a!965well!microtiter!plate!(Appendix!1).!
13.!Loaded!the!samples!into!the!ABI!(Appendix!2).!
!
!
